首页> 外文期刊>Nuclear Medicine Review >A simple and accurate dosimetry protocol to estimate activity for hyperthyroidism treatment
【24h】

A simple and accurate dosimetry protocol to estimate activity for hyperthyroidism treatment

机译:一种简单而准确的剂量学方案,可评估甲亢治疗的活性

获取原文
       

摘要

BACKGROUND: Aim of the study was to evaluate accuracy of different dosimetry protocols in estimating the required 131I activity to treat hyperthyroid patients. MATERIALS AND METHODS: Forty consecutive patients were analysed: twenty-eight Graves’ disease; twelve autonomous thyroid nodule (ATN). Maximum-uptake, effective half-time and residence-time were estimated from Radioiodine Uptake Test. Residence-time was estimated using a bi-compartmental model. For 131I activity calculation, algorithms laid down in European Association of Nuclear Medicine (EANM) guidelines, ICRP 53 approach and a mono-exponential formula (ME), were compared with OLINDA/EXM results. RESULTS: Based on EANM guidelines, activities to be administered were 3% higher in Graves’ disease (p = 0.001) and 3% higher in ATN (p = 0.046). Calculated activities using ICRP 53 approach were significantly lower compared to OLINDA/EXM: 33% in Graves’ disease; 17% in ATN. Activities recommended by ME, were significantly higher: in Graves’ disease 20%; 42% in ATN. CONCLUSIONS: Only EANM algorithm predict quite well, compared to OLINDA/EXM, the required activity to treat hyperthyroid patients.
机译:背景:该研究的目的是评估不同剂量学方案在评估治疗甲状腺功能亢进患者所需的131I活性方面的准确性。材料与方法:连续分析了40例患者:28例格雷夫斯病;十二个自主甲状腺结节(ATN)。通过放射性碘摄取测试估算最大摄取,有效半衰期和停留时间。使用双室模型估算停留时间。对于131I活性计算,将欧洲核医学协会(EANM)指南,ICRP 53方法和单指数公式(ME)中规定的算法与OLINDA / EXM结果进行了比较。结果:根据EANM指南,Graves病的活动量要高出3%(p = 0.001),ATN的活动量要高出3%(p = 0.046)。与OLINDA / EXM相比,使用ICRP 53方法计算得出的活性明显较低:在格雷夫斯病中为33%;在ATN中占17%。我推荐的活动明显更高:在格雷夫斯病中为20%; ATN中的42%。结论:与OLINDA / EXM相比,只有EANM算法能够很好地预测治疗甲状腺功能亢进患者的必要活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号